US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,890.99

-6.2083-0.33%

Number of Gainers:7

Number of Losers:12

Number of Flat:- -

PE:- -

High:1,899.03

Open:1,897.10

Low:1,887.18

Close:1,897.20

Volume:4.42M

Turnover:408.42M

Market Cap:1.54T

Float Cap:1.50T

Loading ...

Equillium Q2 Post Narrower Net Loss than Expected; Starts R&D Initiatives

Aethlon Medical Inc: Q1 EPS of $-4.02

THOMSON REUTERS

Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program

THOMSON REUTERS

Co-Diagnostics Q2 Revenue Rises Slightly Amid International Expansion

Assembly Biosciences Q2 Net Loss Narrows as Revenue Rises

Equillium Q2 Basic EPS USD -0.04

THOMSON REUTERS

Press Release: Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Co-Diagnostics Q2 EPS $(1.46) Beats $(3.00) Estimate, Sales $166.131K Miss $166.500K Estimate

Benzinga Earnings

Co-Diagnostics Q2 FY26 Net Loss Narrows to USD 6.3 Million; Revenue Rises to USD 166,131

Co-Diagnostics Q2 Revenue USD 170 Thousand

Co-Diagnostics Q2 Adjusted Ebitda USD -5.8 Million

THOMSON REUTERS

Co-Diagnostics Q2 EPS Usd -1.46

THOMSON REUTERS

Moderna Expands Respiratory Vaccine Pipeline With New RSV/hMPV Trial in Older Adults

AstraZeneca’s STEP Asthma Trial Completion: What It Could Mean for AZN Investors

Your Prescription Drugs Shouldn't Cost More than Your Mortgage. Inside the Broken Math That Got US Here.

2026 Health Industry Summit Explores Pharmacy Evolution: From Drug Retailers to Community Wellness Hubs

EQ Resources Seeks ASX Quotation for 3.3 Million New Shares

Olema Pharmaceuticals Names Jason O’Byrne CFO

APT Electronics Sets Board Meeting to Review 2026 Interim Results and Dividend

Pfizer (PFE) Could Be 10% Undervalued Following Raised Revenue Guidance

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK4568/news?page=14"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1890.9944,"timestamp":1787578280389,"preClose":1897.2026,"halted":0,"volume":4434603,"delay":0,"changeRate":-0.003272,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-6.208252,"latestTime":"08-24 09:31:20 EDT","open":1897.095,"high":1899.0317,"low":1887.1771,"amount":408419884.284451,"amplitude":0.006248,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.86817,"peRate":47.42362,"turnoverRate":0.00032,"increases":7,"decrements":12,"flats":0,"marketCap":1539498473624,"floatMarketCap":1502581344321.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1899.0317,"amplitude":0.006248,"preClose":1897.2026,"low":1887.1771,"pbRate":"4.86817","latestPrice":1890.9893,"volume":4415471,"delay":0,"open":1897.095,"prevYearClose":1637.1339,"prevWeekClose":1897.2026,"prevMonthClose":1741.4208,"prevQuarterClose":1731.2963,"fiveDayClose":1778.7885,"twentyDayClose":1765.6205,"sixtyDayClose":1666.712,"secType":"PLATE","market":"US","turnoverRate":0.000319,"peRate":47.42362,"marketCap":1539399540888,"floatMarketCap":1502485804097.5,"timestamp":1787578277366,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":7,"down":12,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:14,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659673481","title":"Equillium Q2 Post Narrower Net Loss than Expected; Starts R&D Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2659673481","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659673481?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:20","pubTimestamp":1786652418,"startTime":"0","endTime":"0","summary":"Equillium Q2 post narrower net loss than expected; starts R&D initiativesOverviewUS biotech innovator's Q2 net loss narrowed and beat analyst expectationsQ2 loss per share beat analyst expectationsCom","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A159:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","EQ","NKTX","ARTL","BK4568","BK4139","BK4007","FATE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659193629","title":"Aethlon Medical Inc: Q1 EPS of $-4.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2659193629","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659193629?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA2D4XW8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AEMD","BK4583","BK4568","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162057","title":"Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162057?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA2D4XW8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AEMD","BK4583","BK4568","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659624451","title":"Co-Diagnostics Q2 Revenue Rises Slightly Amid International Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2659624451","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659624451?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:10","pubTimestamp":1786651818,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Q2 revenue rises slightly amid international expansionOverviewUS molecular diagnostics firm Q2 revenue rose slightly yr/yr on higher product salesNet loss for Q2 narrowed from prior yea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A142:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4121","TECH","IE0034390439.USD","LU0205193047.USD","CODX","BK4588","BK4585","LU0205194284.USD","IE00B19Z6F94.USD","LU2237957902.USD","IE00B64QTZ34.USD","BK4082","LU2237957811.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162459","title":"Assembly Biosciences Q2 Net Loss Narrows as Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162459","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162459?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:09","pubTimestamp":1786651778,"startTime":"0","endTime":"0","summary":"Assembly Biosciences Q2 net loss narrows as revenue risesOverviewUS biotech firm's Q2 revenue from Gilead collaboration rose yr/yr, net loss narrowedLower net loss driven by higher revenue, reduced R&","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A13Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","LU1571399168.USD","SG9999015978.USD","IE00B3T34201.USD","LU2112291526.USD","BK4568","LU1674673691.USD","LU0114720955.EUR","BIB","LU1066053197.SGD","IBBQ","LU1934455194.USD","BBH","LU2087621335.USD","LU2468319806.SGD","NKTX","LU0882574055.USD","SG9999015986.USD","LU0122379950.USD","BK4505","BK4566","LU1839511570.USD","ARTL","LU0320765992.SGD","LU1061106388.HKD","ASMB","BK4007","LU1585245621.USD","LU0965509283.SGD","LU0109394709.USD","LU1934455277.USD","IE00B19Z3581.USD","LU1023059063.AUD","LU0965508806.USD","IE00BZ1G4Q59.USD","MEDI","LU0289739699.SGD","LU0889565916.HKD","BK4578","TBXU","LU1674673428.USD","AVIR","BK4588","IBB","BMED","BK4139","LU1057294990.SGD","LU0965509010.AUD","TMED","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162312","title":"Equillium Q2 Basic EPS USD -0.04","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162312?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651505,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nPLXWVW3FT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EQ","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162993","title":"Press Release: Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162993","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162993?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"-- Achieved Q2 2026 PEMGARDA  net product revenue of $14.3. million, representing 21% growth versus Q2 2025 net product revenue of. -- Completed rapid enrollment in VYD2311 DECLARATION clinical trial. expansion cohort and LIBERTY clinical trial, driven by strong subject. -- DECLARATION pivotal clinical trial enrollment is complete; the ongoing. study is approaching its planned analysis, and in lieu of a Q2 2026. quarterly earnings call, Invivyd plans to hold an investor call post. -- Strong balance sheet with Q2 2026 ending cash and cash equivalents of. $160.1 million anticipated to provide runway through DECLARATION pivotal. data readout and support potential commercial launch readiness for. 30, 2026, compared to $11.8 million in for the quarter ended June 30,-- In July 2026, Invivyd announced receipt of twelve months' advanced notice. of emergency use authorization  termination for PEMGARDA and that. the company is in dialogue with the U.S. Food and Drug Administration.  about approp","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4551","BK4535","BK4585","BK4539","IVVD","MEDX","NVIB","BK4568","GDOC","R","BNTX","IDNA","BK4022","HYLG","BK4548","IND","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162935","title":"Co-Diagnostics Q2 EPS $(1.46) Beats $(3.00) Estimate, Sales $166.131K Miss $166.500K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162935","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162935?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:04","pubTimestamp":1786651442,"startTime":"0","endTime":"0","summary":"Co-Diagnostics (OTC:CODX) reported quarterly losses of $(1.46) per share which beat the analyst consensus estimate of $(3.00) by 51.33 percent. This is a 78.84 percent increase over losses of $(6.90) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61191898/co-diagnostics-q2-eps-1-46-beats-3-00-estimate-sales-166-131k-miss-166-500k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Co-Diagnostics Q2 EPS $(1.46) Beats $(3.00) Estimate, Sales $166.131K Miss $166.500K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4568","CODX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659916401","title":"Co-Diagnostics Q2 FY26 Net Loss Narrows to USD 6.3 Million; Revenue Rises to USD 166,131","url":"https://stock-news.laohu8.com/highlight/detail?id=2659916401","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659916401?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:02","pubTimestamp":1786651328,"startTime":"0","endTime":"0","summary":"Co-Diagnostics Q2 FY26 net loss narrows to USD 6.3 million; revenue rises to USD 166,131Co-Diagnostics posted a GAAP net loss of $6.3 million, or $1.46 per share, in Q2 2026.Operating loss narrowed to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL8PbMCd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659164015","title":"Co-Diagnostics Q2 Revenue USD 170 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2659164015","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659164015?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:02","pubTimestamp":1786651320,"startTime":"0","endTime":"0","summary":"BRIEF-Co-Diagnostics Q2 Revenue USD 170 ThousandAug 13 (Reuters) - Co-Diagnostics Q2 net income USD -6.3 million.Q2 operating income USD -6.2 millionQ2 adjusted EBITDA USD -5.8 millionQ2 operating expenses USD 6.3 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nPLXBTLFFR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CODX","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659164793","title":"Co-Diagnostics Q2 Adjusted Ebitda USD -5.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659164793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659164793?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:01","pubTimestamp":1786651260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nPLXBTLFFR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659078164","title":"Co-Diagnostics Q2 EPS Usd -1.46","url":"https://stock-news.laohu8.com/highlight/detail?id=2659078164","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659078164?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:01","pubTimestamp":1786651260,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nPLXBTLFFR:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CODX","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166082","title":"Moderna Expands Respiratory Vaccine Pipeline With New RSV/hMPV Trial in Older Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166082","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166082?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:30","pubTimestamp":1786638638,"startTime":"0","endTime":"0","summary":"Moderna ($MRNA) announced an update on their ongoing clinical study. ModernaTX, Inc. has launched a new early-stage trial called “A Phase 1, Random...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/moderna-expands-respiratory-vaccine-pipeline-with-new-rsv-hmpv-trial-in-older-adults?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/moderna-expands-respiratory-vaccine-pipeline-with-new-rsv-hmpv-trial-in-older-adults?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","MRNA","BK4532","GNOM","BK4588","BK4534","BK4551","MRNY","BK4501","BK4139","BK4568","BK4585","MRNX","BK4548","LGHT","BK4533","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166055","title":"AstraZeneca’s STEP Asthma Trial Completion: What It Could Mean for AZN Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166055","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166055?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:30","pubTimestamp":1786638610,"startTime":"0","endTime":"0","summary":"AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The STEP Phase 3b study from AstraZeneca looks at whether patients with se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazenecas-step-asthma-trial-completion-what-it-could-mean-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazenecas-step-asthma-trial-completion-what-it-could-mean-for-azn-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","LU0320765992.SGD","BK4568","LU0432979614.USD","AZN","LU0109394709.USD","LU0310800379.SGD","LU2237443382.USD","LU0058720904.USD","LU0128525929.USD","BK4007","AZNH","LU0889565916.HKD","LU2417539215.USD","LU2237443549.SGD","LU2237443895.HKD","STEP","LU2468319806.SGD","LU2237443465.HKD","LU0708994859.HKD","LU2237443622.USD","LU0029864427.USD","LU2236285917.USD","BK4585","BK4588","LU1829250122.USD","LU2456880835.USD","BK4135","LU0289739699.SGD","LU2237443978.SGD","LU2462157665.USD","LU1267930573.SGD","BK4211","LU2089984988.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165887","title":"Your Prescription Drugs Shouldn't Cost More than Your Mortgage. Inside the Broken Math That Got US Here.","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165887","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165887?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:02","pubTimestamp":1786633320,"startTime":"0","endTime":"0","summary":"Here's how I would fix drug pricesThe same system that motivates companies to seek out innovative therapies may also engender bad behavior.For many Americans, the price of prescription drugs is an eni","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","IE00BZ1G4Q59.USD","LU2468319806.SGD","LU1061106388.HKD","IE00B7SZLL34.SGD","SG9999015986.USD","LU0058720904.USD","LU0965509283.SGD","SG9999015952.SGD","BIB","SG9999015945.SGD","BK4588","LU0965509010.AUD","BK4532","LU1839511570.USD","LU1023059063.AUD","BK4578","LU1778281490.HKD","GILD","LU1066051498.USD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4550","LU0109394709.USD","IE0002270589.USD","LU1585245621.USD","LU1057294990.SGD","LU0823416689.USD","BK4568","IBB","SG9999015978.USD","LU0320765992.SGD","BBH","IBBQ","MEDI","LU2089984988.USD","TBXU","BK4566","TMED","IE00B19Z3B42.SGD","BK4139","LU1430594728.SGD","LU2087621335.USD","LU2324357040.USD","IE00BSNM7G36.USD","BK4585","LU1571399168.USD","LU0114720955.EUR","BMED","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114041871","title":"2026 Health Industry Summit Explores Pharmacy Evolution: From Drug Retailers to Community Wellness Hubs","url":"https://stock-news.laohu8.com/highlight/detail?id=1114041871","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114041871?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:38","pubTimestamp":1786624729,"startTime":"0","endTime":"0","summary":"On the afternoon of August 12, 2026, a deep discussion on the future form of retail pharmacies took place in the main hall of the Boao Forum for Asia Hotel. As a key part of the Health Industry...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","SG9999002232.USD","002727","LU0289739699.SGD","LU0225771236.USD","LU0456855351.SGD","SG9999014674.SGD","LU0225284248.USD","SGXZ57979304.SGD","SG9999011175.SGD","LU1894683348.USD","BK0164","BK0097","LU1993786604.SGD","BK0209","BK4581","BK0012","BK4592","BK4585","BK0077","LU0170899867.USD","LU2596442595.SGD","LU1807302812.USD","LU1883839398.USD","LU1894683264.USD","IE00BLSP4452.SGD","SG9999003800.SGD","LU0321505868.SGD","LU2328871848.SGD","LU1969619763.USD","BK4588","LU1960683339.HKD","LU0058720904.USD","LU0868494617.USD","IE00BLSP4239.USD","LU1066051498.USD","000538","BK4568","IE00B19Z3581.USD","PFE","301017","SG9999013999.USD","LU0234572021.USD","BK4550","BK0183","BK4533","SG9999001176.SGD","BK0196","LU0306807586.USD","BK0175","BK0188","IE00B3T34201.USD","IE00BBT3K403.USD","SG9999001176.USD","LU1023059063.AUD","LU0306806265.USD","SG9999004220.SGD","BK0028","BK0187","IE00B19Z3B42.SGD","SG9999002224.SGD","OZEM","LU0321505439.SGD","BK0239","IE000M9KFDE8.USD","000423","LU0122379950.USD","LU0985481810.HKD","LU1057294990.SGD","BK4007","LU1066053197.SGD","BK0010","IE0002270589.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659559159","title":"EQ Resources Seeks ASX Quotation for 3.3 Million New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2659559159","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659559159?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:09","pubTimestamp":1786619343,"startTime":"0","endTime":"0","summary":"EQ Resources Limited ( ($AU:EQR) ) has shared an update. EQ Resources Limited has applied for quotation on the ASX of 3,313,441 new ordinary fully ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eq-resources-seeks-asx-quotation-for-3-3-million-new-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eq-resources-seeks-asx-quotation-for-3-3-million-new-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4568","EQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156977","title":"Olema Pharmaceuticals Names Jason O’Byrne CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156977","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156977?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:05","pubTimestamp":1786619159,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals names Jason O’Byrne CFOOlema Pharmaceuticals named Jason O’Byrne chief financial officer as it prepares for pivotal OPERA-01 data and a potential first commercial launch.O’Byrne ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL2kwyYz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIR","BK4139","BK4535","BK4585","BK4568","OLMA","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659300391","title":"APT Electronics Sets Board Meeting to Review 2026 Interim Results and Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2659300391","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659300391?lang=en_us&edition=fundamental","pubTime":"2026-08-13 17:38","pubTimestamp":1786613927,"startTime":"0","endTime":"0","summary":"APT Electronics Co., Ltd. Class H ( ($HK:2551) ) has shared an announcement. APT Electronics Co., Ltd., a Hong Kong-listed Chinese electronics comp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apt-electronics-sets-board-meeting-to-review-2026-interim-results-and-dividend?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apt-electronics-sets-board-meeting-to-review-2026-interim-results-and-dividend?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4086","APT","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659130102","title":"Pfizer (PFE) Could Be 10% Undervalued Following Raised Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2659130102","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659130102?lang=en_us&edition=fundamental","pubTime":"2026-08-13 17:26","pubTimestamp":1786613176,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) is back in focus after its second quarter results came in ahead of internal expectations, prompting the company to lift full year revenue guidance and spotlight progress in key non COVID therapies.\nSee our latest analysis for Pfizer.\nPfizer's recent earnings beat, higher full year revenue guidance and progress in drugs like Eliquis and LITFULO have coincided with a 7.5% 30 day share price return and an 11.9% 1 year total shareholder return, although longer term total shareholder...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/162270-main-header/1756254067137","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/162270-main-header/1756254067137"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/pfizer-pfe-could-be-10-undervalued-following-raised-revenue","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/pfizer-pfe-could-be-10-undervalued-following-raised-revenue","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4533","LU0058720904.USD","LU0306807586.USD","SG9999002224.SGD","LU0122379950.USD","IE00BLSP4239.USD","LU2596442595.SGD","SG9999002232.USD","IE00B19Z3B42.SGD","LU1066051498.USD","LU1066053197.SGD","BK4550","BK4534","LU1894683348.USD","IE00BBT3K403.USD","SG9999003800.SGD","IE00BLSP4452.SGD","IE00B3T34201.USD","BK4599","IE0002270589.USD","LU0306806265.USD","LU0321505439.SGD","SG9999001176.USD","PFE","BK4007","LU0289739699.SGD","SGXZ57979304.SGD","IE00B19Z3581.USD","LU0234572021.USD","LU1057294990.SGD","BK4585","LU0321505868.SGD","SG9999011175.SGD","OZEM","SG9999013999.USD","LU0225771236.USD","BK4581","LU0985481810.HKD","LU0170899867.USD","LU1894683264.USD","LU0868494617.USD","IE000M9KFDE8.USD","LU1883839398.USD","BK4592","LU0225284248.USD","LU0456855351.SGD","BK4568","SG9999001176.SGD","LU1023059063.AUD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":14,"totalSize":324,"code":"91000000","status":"200"}]}}